615
Views
0
CrossRef citations to date
0
Altmetric
Review

Choroidal Perfusion Changes After Vitrectomy for Myopic Traction Maculopathy

, , &
Pages 261-270 | Received 06 Jun 2023, Accepted 09 Nov 2023, Published online: 21 Nov 2023
 

ABSTRACT

Background

The choroidal vasculature supplies the outer retina and is altered in many retinal diseases, including myopic traction maculopathy (MTM). Choroid health is typically assessed by measuring the choroidal thickness; however, this method has substantial limitations. The choroidal vascularity index (CVI) was recently introduced to provide quantitative information on the vascular flow in the choroid. This index has been evaluated in a wide range of diseases but has not been extensively used to characterize MTM.

Aim

This study aimed to investigate the CVI across different stages of MTM and the influence of macular surgery on choroidal perfusion markers in different surgically resolved MTM stages.

Methods

Eighteen healthy myopic eyes in the control group and forty-six MTM eyes in the surgical group were evaluated using enhanced optical coherence tomography (OCT) imaging. Binarized OCT images were processed to obtain the luminal choroidal area (LCA) and stromal choroidal area (SCA), which were used to calculate CVI in the form of a percentage ratio. CVI data were collected at baseline, one and four months postoperatively, and at the final clinical visit. MTM eyes were divided into four stages based on disease severity. The choriocapillaris flow area (CFA) and central subfield thickness (CSFT) were measured along side the CVI.

Results

No significant differences were observed between the two groups at baseline, except for visual acuity (p  < 0.0001). Surgery significantly improved vision at all postoperative time points (p  < 0.0001). At baseline, there were no significant differences in CVI, CFA, or CSFT scores between the control and surgical groups. However, all three measurements were lower at the final visit in the surgical group (p ≤0.0001). No significant differences were found in any of the parameters among the four stages of MTM (p  > 0.05). Ultimately, correlation and multivariate linear regression analyses did not reveal any significant association between CVI and visual acuity.

Conclusions

This study did not find significant preoperative differences in CVI between healthy myopic eyes and eyes with MTM. However, the postoperative CVI and CFA values were significantly lower than those of the control eyes. Thus, CVI may not be a good biomarker for surgical outcomes, as the correlation between CVI and visual acuity was not statistically significant.The CVI and CFA decreased after surgery, providing evidence of choroidal changes after surgical management.

ABBREVIATIONS

ATN=

atrophic (A), tractional (T), and neovascular (N)

BCVA=

best-corrected visual acuity

CFA=

choriocapillaris foveal area

CFT=

central foveal thickness

CSP=

choriocapillaris subfoveal plexus

CSFT=

central subfield thickness

CVI=

choroidal vascularity index

ERM=

epiretinal membrane

FS-ILM=

foveal sparing ILM peeling technique

FRD=

foveoretinal detachment

ILM=

internal limiting membrane

LCA=

luminal choroidal area

LogMAR=

logarithm of the minimum angle of resolution

FS=

foveoschisis

MH=

macular hole

MHRD=

macular hole retinal detachment

MTM=

myopic traction maculopathy

OCT=

optical coherence tomography

OCT=

A optical coherence tomography angiography

PPV=

pars plana vitrectomy

PM=

pathologic myopia

PS=

posterior staphyloma

PVR=

proliferative vitreoretinopathy

RPE=

retinal pigment epithelium

RRD=

rhegmatogenous retinal detachment

RD=

retinal detachment

SD-OCT=

spectral-domain OCT

SCA=

stromal choroidal area

SRF=

subretinal fluid

TCA=

total choroidal area

ACKNOWLEDGMENTS

We express our deep appreciation to the technical staff of the Retina Department of Oftalmologia Integral ABC (a Medical and Surgical Nonprofit Organization), Mexico City, Mexico, which is affiliated with The Postgraduate Division Studies at the National Autonomous University of Mexico.

DISCLOSURE STATEMENT

No potential conflict of interest was reported by the author(s).

DATA AVAILABILITY STATEMENT

The datasets used in this study have been included in the main text. Photographs and figures from this study may be released via a written application to the Photographic Laboratory and Clinical Archives Retina Department at the Oftalmologia Integral ABC, Medical and Surgical Assistance Institution (Nonprofit Organization), Av. Paseo de las Palmas 735 suite 303, Lomas de Chapultepec, Mexico City 11,000, Mexico and the corresponding author upon request. The data analysis can be found in the supplementary file.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

This study adhered to the tenets of the Declaration of Helsinki and received full approval from the appropriate research ethics committee, institutional review committee, and institutional teaching department (the institutions did not provide reference numbers for the retrospective studies).

AUTHOR CONTRIBUTIONS

MAQR, study conception, writing the manuscript, dataset interpretation, statistical analysis interpretation, final revision, conclusions; EAQG, figure artwork, tables, material compilation; MAQG, figure and table construction; VLG, statistical analysis and final revision. All the authors have approved the manuscript for submission.

INSTITUTIONAL REVIEW BOARD STATEMENT

This study was conducted at the Retina Department of the Oftalmologia Integral ABC Institution in Mexico City. The institutional review board approved the study according to the institutional guidelines. No reference number was provided for the retrospective studies at this institution.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.